Nasdaq:US$14.76 (-0.28) | HKEX:HK$23.22 (-0.20) | AIM:£2.24 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor